medigraphic.com

2017, Número S1

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2017; 55 (S1)


Prediabetes como marcador de riesgo para hiperglucemia inducida por estrés en pacientes adultos críticamente enfermos

García-Gallegos DJ, Luis-López E

Idioma: Español
Referencias bibliográficas: 24
Paginas: 14-19
Archivo PDF: 286.17 Kb.


RESUMEN

Introducción: no se conoce si los pacientes con prediabetes, un subgrupo de pacientes no diabéticos que generalmente cursan con hiperinsulinemia, tienen mayor riesgo de presentar hiperglucemia inducida por estrés. El objetivo fue determinar si la prediabetes es un marcador de riesgo para presentar hiperglucemia inducida por estrés.
Métodos: estudio analítico, observacional, prospectivo de cohorte en pacientes críticos sin antecedentes de diabetes mellitus de un hospital de tercer nivel. Se determinó al ingreso la glucosa plasmática y la hemoglobina glucosilada (HbA1c) para diagnosticar hiperglucemia de estrés (glucosa ≥ 140 mg/dL) y prediabetes (HbA1c entre 5.7 y 6.4%), respectivamente. Se examinó la proporción de pacientes sin prediabetes y prediabéticos que desarrollaron hiperglucemia de estrés con tablas de contingencia y prueba exacta de Fisher para escalas nominales.
Resultados: 73 pacientes se estudiaron y se encontró una proporción de hiperglucemia de estrés en pacientes sin prediabetes de 6.6 y 61.1% en los pacientes con prediabetes. La prueba exacta de Fisher dio 22.46 (p ‹ 0.05).
Conclusión: la prediabetes es un marcador de riesgo para hiperglucemia de estrés en el paciente adulto críticamente enfermo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001 Jan;17(1): 107-24.

  2. Barton RN. Neuroendocrine mobilization of body fuels after injury. Br Med Bull. 1985;41:218-25.

  3. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009 May 23;373(9677):1798- 807. doi: 10.1016/S0140-6736(09)60553-5.

  4. Van den Berghe G1, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67.

  5. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625.

  6. Graham BB, Keniston A, Gajic O, Trillo-Alvarez CA, Medvedev S, Douglas IS. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med. 2010;38(1):16-24.

  7. Kompoti M, Michalia M, Salma V, Diogou E, Lakoumenta A, Clouva-Molyvdas PM. Glycated hemoglobin at admission in the intensive care unit: Clinical implications and prognostic relevance. Journal of Critical Care. 2015;30(1):150-5.

  8. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-61. doi: 10.1056/NEJMoa052521.

  9. Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;15: 151-60.

  10. Dandona P, Chaudhuri A, Mohanty P, Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):511-7.

  11. Woodske ME, Yokoe T, Zou B, Romano LC, Rosa TC, Garcia-Ocana A, et al. Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness. Crit Care Med. 2009 Sep;37(9):2596- 603. doi: 10.1097/CCM.0b013e3181a9338a

  12. Wolfe RR, Martini WZ. Changes in intermediary metabolism in severe surgical illness. World J Surg. 2000 Jun;24(6):639-47.

  13. Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014 Jul;40(7):973-80. doi: 10.1007/s00134-014-3287-7.

  14. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006; 27:2716- 24. DOI: http://dx.doi.org/10.1093/eurheartj/ehi855

  15. De la Rosa GC, Donado JH, Restrepo AH, Quintero AM, González MG, Saldarriaga NE et al. Strict glycaemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial. Crit Care. 2008; 12(5): R120. doi: 10.1186/cc7017

  16. Sun Q, Li J, Gao F. New insights into insulin: The anti-inflammatory effect and its clinical relevance. World J Diabetes. 2014;15;5(2):89-96. doi: 10.4239/ WJD.v5.i2.89

  17. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002 Oct 15;106(16):2067-72.

  18. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, CDC; 2011.

  19. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008 Aug;36(8):2249-55. doi: 10.1097/CCM.0b013e318181039a.

  20. Saberi F, Heyland D, Lam M, Rapson D, Jeejeebhoy K. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr. 2008 May- Jun;32(3):227-35. doi: 10.1177/0148607108316195.

  21. Abhyankar S, Leishear K, Callaghan FM, Demner- Fushman D, McDonald CJ. Lower short and longterm mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients. Crit Care. 2012; 16(6): R235. doi: 10.1186/ cc11903

  22. Gornik I, Vujaklija-Brajkovi A, Gašparović V. Validation of HbA1c as a diagnostic marker for diabetes in the critically ill. Crit Care. 2010; 14(Suppl 1): P581. doi: 10.1186/cc8813

  23. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716.

  24. Deane AB, Plummer MP, Cousins CE, Annink CE, Sundararajan, Reddi BA, et al. The Impact of Premorbid Glycemia On The Association Between Acute Hyperglycemia And Mortality In Critically Ill Patients. Am J Respir Crit Care Med. 2014;189:A2525.




2020     |     www.medigraphic.com